Quantum-Mechanics and Machine Learning Drug Discovery.
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists.
The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research.
Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties (ADME, Tox, ...), obtaining insights of ligand / receptor interactions and identifying original backup compounds.
Learn more on how to de-risk your drug discovery project by emailing us at contact@pharmacelera.com or by visiting our webpage at www.pharmacelera.com
Location: Spain, Catalonia, Barcelona
Member count: 11-50
Total raised: $1.080499M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | The Collid... | thecollide... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 03.04.2020 | - | $1.080499M | - | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 16.11.2018 | Next November 15 will take place the 23rd Forum of Investmen... | On November 15, the 23rd Healthcare Barcelona Investment Forum will be held at the CoMB headquarters... | startupsre... |
| 28.07.2017 | How Barcelona’s Health Becomes Digital | Barcelona and Catalonia are renowned for its powerful life sciences research and the quality of the ... | barcinno.c... |